Evome Medical Technologies Inc. financial data

Symbol
LNDZF on OTC
Location
Suite 2700,, 1133 Melville Street, Vancouver, British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-K - Q4 2023 - Apr 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 59.1 % -32.6%
Quick Ratio 27.2 % -7.54%
Debt-to-equity 350 % +101%
Return On Equity -117 % -28.7%
Return On Assets -26.1 % +21.3%
Operating Margin -8.82 % -181%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.8M shares +6.8%
Common Stock, Shares, Outstanding 57M shares +6.11%
Entity Public Float 11.3M CAD -52.7%
Common Stock, Value, Issued 39.7M CAD +2.46%
Weighted Average Number of Shares Outstanding, Basic 73.5M shares +33.2%
Weighted Average Number of Shares Outstanding, Diluted 73.5M shares +33.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 62.6M CAD +56.6%
Cost of Revenue 40.1M CAD +49.5%
General and Administrative Expense 23.5M CAD +79.7%
Operating Income (Loss) -5.52M CAD -339%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.5M CAD +1.92%
Income Tax Expense (Benefit) 57.1K CAD
Net Income (Loss) Attributable to Parent -15.6M CAD -0.19%
Earnings Per Share, Basic 0 CAD/shares
Earnings Per Share, Diluted 0 CAD/shares +27.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 919K CAD -52.4%
Accounts Receivable, after Allowance for Credit Loss, Current 7.8M CAD +22.8%
Inventory, Net 10.2M CAD +26.4%
Assets, Current 21M CAD +26.5%
Property, Plant and Equipment, Net 3.42M CAD +0.52%
Operating Lease, Right-of-Use Asset 9.64M CAD +23.9%
Intangible Assets, Net (Excluding Goodwill) 7.03M CAD -25.1%
Goodwill 6.4M CAD -53.3%
Assets 48.3M CAD -7.29%
Accounts Payable, Current 6.91M CAD +31.1%
Accrued Liabilities, Current 1.75M CAD +27.5%
Liabilities, Current 37.6M CAD +24.6%
Operating Lease, Liability, Noncurrent 6.43M CAD +7.41%
Liabilities 44.3M CAD +20.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.21M CAD +30.9%
Retained Earnings (Accumulated Deficit) -64.9M CAD -31.7%
Stockholders' Equity Attributable to Parent 4M CAD -73.9%
Liabilities and Equity 48.3M CAD -7.29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -824K CAD +32.7%
Net Cash Provided by (Used in) Financing Activities 2.58M CAD -43.4%
Net Cash Provided by (Used in) Investing Activities -93.2K CAD +84.3%
Common Stock, Shares, Issued 57M shares +6.11%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 919K CAD -52.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 173K CAD +170%
Deferred Tax Assets, Valuation Allowance 5.7M CAD +99.6%
Operating Lease, Liability 7.91M CAD +15.8%
Depreciation 1M CAD +117%
Payments to Acquire Property, Plant, and Equipment 93.2K CAD +302%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.1M CAD -3.4%
Property, Plant and Equipment, Gross 5.02M CAD +3.63%
Operating Lease, Liability, Current 1.48M CAD +74.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16.3%
Deferred Income Tax Expense (Benefit) -193K CAD -68.9%
Operating Lease, Payments 339K CAD
Additional Paid in Capital 9.74M CAD +20.6%
Operating Leases, Future Minimum Payments, Due in Two Years 1.96M CAD +53.8%
Amortization of Intangible Assets 1.48M CAD +45.2%
Depreciation, Depletion and Amortization 917K CAD +147%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1.91M CAD +55.6%
Deferred Tax Assets, Net of Valuation Allowance 3.24M CAD +13.1%
Share-based Payment Arrangement, Expense 265K CAD -30.1%
Operating Leases, Future Minimum Payments, Due in Three Years 1.43M CAD +8.87%
Operating Leases, Future Minimum Payments Due 10.8M CAD +19.3%
Interest Expense 2.64M CAD +301%